Eventide Asset Management - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 171 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$5,784,000
-61.4%
75,000
-57.9%
0.21%
-65.9%
Q2 2018$14,993,000
+3.0%
178,0000.0%0.62%
-8.8%
Q1 2018$14,557,000
+19.0%
178,000
-16.8%
0.68%
+6.9%
Q4 2017$12,234,000
-14.4%
214,0000.0%0.64%
-21.2%
Q3 2017$14,285,000
-7.7%
214,000
-28.9%
0.81%
-16.0%
Q2 2017$15,476,000
-11.9%
300,8000.0%0.96%
-17.1%
Q1 2017$17,567,000
+40.0%
300,8000.0%1.16%
+42.4%
Q4 2016$12,552,000
-21.0%
300,8000.0%0.82%
-15.8%
Q3 2016$15,888,000
+26.1%
300,8000.0%0.97%
+25.8%
Q2 2016$12,602,000
+3.2%
300,8000.0%0.77%
+13.0%
Q1 2016$12,212,000
-37.5%
300,8000.0%0.68%
-30.1%
Q4 2015$19,528,000
+13.0%
300,800
+22.8%
0.98%
-2.8%
Q3 2015$17,287,000
-6.4%
244,900
+47.4%
1.00%
+0.5%
Q2 2015$18,471,000
+17.9%
166,2000.0%1.00%
-15.3%
Q1 2015$15,673,000
-45.8%
166,200
-35.6%
1.18%
-62.7%
Q4 2014$28,929,000
+9.3%
258,200
-40.2%
3.16%
-14.6%
Q3 2014$26,479,000
+17.8%
431,600
-12.0%
3.70%
+21.0%
Q2 2014$22,475,000
+26.4%
490,500
+8.0%
3.06%
+10.7%
Q1 2014$17,782,000
+255.6%
454,200
+117.5%
2.76%
+79.1%
Q4 2013$5,001,000208,8001.54%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,710,061$67,074,0101.80%
Bellevue Group AG 4,013,500$99,334,1251.60%
Eagle Health Investments LP 267,630$6,623,8431.46%
ARMISTICE CAPITAL, LLC 3,324,000$82,269,0001.26%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$11,236,5000.61%
Frazier Life Sciences Management, L.P. 292,002$7,227,0500.48%
ArrowMark Colorado Holdings LLC 1,573,359$38,940,6350.47%
Deep Track Capital, LP 422,247$10,450,6130.40%
FARALLON CAPITAL MANAGEMENT LLC 2,750,829$68,083,0180.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 24,000$593,5200.20%
View complete list of AGIOS PHARMACEUTICALS INC shareholders